DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Bithionol

Bithionol

  • AHFS Pharmacologic-Therapeutic Classification System

    AHFS Pharmacologic-Therapeutic Classification System

  • SUPPLEMENTARY TABLES Compounds Pharmacology

    SUPPLEMENTARY TABLES Compounds Pharmacology

  • ROS) in Cisplatin Chemotherapy: a Focus on Molecular Pathways and Possible Therapeutic Strategies

    ROS) in Cisplatin Chemotherapy: a Focus on Molecular Pathways and Possible Therapeutic Strategies

  • Withdrawing Drugs in the U.S. Versus Other Countries Benson Ninan

    Withdrawing Drugs in the U.S. Versus Other Countries Benson Ninan

  • (12) United States Patent (10) Patent No.: US 8,623,335 B2 Waddington (45) Date of Patent: Jan

    (12) United States Patent (10) Patent No.: US 8,623,335 B2 Waddington (45) Date of Patent: Jan

  • Compounds and Bulk Powders

    Compounds and Bulk Powders

  • (12) United States Patent (10) Patent No.: US 8,911,773 B2 Kimball (45) Date of Patent: *Dec

    (12) United States Patent (10) Patent No.: US 8,911,773 B2 Kimball (45) Date of Patent: *Dec

  • VIEW Open Access Novel Drugs That Target the Metabolic Reprogramming in Renal Cell Cancer Johannes C

    VIEW Open Access Novel Drugs That Target the Metabolic Reprogramming in Renal Cell Cancer Johannes C

  • Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……

    Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Drugs for Parasitic Infections (2013 Edition)

    Drugs for Parasitic Infections (2013 Edition)

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • In Vitro Toxicity of Bithionol and Bithionol Sulphoxide to Neoparamoeba Spp., the Causative Agent of Amoebic Gill Disease (AGD)

    In Vitro Toxicity of Bithionol and Bithionol Sulphoxide to Neoparamoeba Spp., the Causative Agent of Amoebic Gill Disease (AGD)

  • Final Report

    Final Report

  • Suppl Table 2.Xlsx

    Suppl Table 2.Xlsx

  • CNS DRUGS 1. \\\\ Lorazepam Can Be Safely Used As a Preanesthetic

    CNS DRUGS 1. \\\\ Lorazepam Can Be Safely Used As a Preanesthetic

  • Whelan 1,2 Martin Danaher 1, Ambrose Furey 2

    Whelan 1,2 Martin Danaher 1, Ambrose Furey 2

  • Amebic Meningoencephalitis.Qxd

    Amebic Meningoencephalitis.Qxd

Top View
  • Drug Release of Polymeric Pharmaceuticals
  • Management and Utilization of Orphan Drugs Against Parasitic Infections in Recent 7 Years in Japan
  • ( 12 ) United States Patent
  • Compounded Medications
  • Solutions Your Api Intermediates
  • Distributeur Courtage Analyses Services 14 Rue De Mouettes 76130 Mont Saint Aignan Tel +33 (0) 2 35 07 60 00 Fax +33 (0)
  • United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
  • Multi-Discipline Review
  • Correlation Between Drug Market Withdrawals and Socioeconomic, Health, and Welfare Indicators Worldwide
  • Title 21 Food and Drugs Parts 300 to 499
  • Determination of Anthelmintic and Antiprotozoal Drug Residues in Fish Using Liquid Chromatography-Tandem Mass Spectrometry
  • European Patent Office of Opposition to That Patent, in Accordance with the Implementing Regulations
  • AAEP Parasite Control Guidelines
  • (12) United States Patent (10) Patent No.: US 7,921,999 B1 Kimball (45) Date of Patent: Apr
  • (12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • The Medical Letter


© 2024 Docslib.org    Feedback